melanotan II
Selected indexed studies
- Melanotan II: a possible cause of renal infarction: review of the literature and case report. (CEN Case Rep, 2020) [PMID:31953620]
- Melanotan-II reverses memory impairment induced by a short-term HF diet. (Biomed Pharmacother, 2023) [PMID:37478579]
- Melanotan II User Experience: A Qualitative Study of Online Discussion Forums. (Dermatology, 2021) [PMID:34464955]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Melanotan II: a possible cause of renal infarction: review of the literature and case report. (2020) pubmed
- Melanotan-II reverses memory impairment induced by a short-term HF diet. (2023) pubmed
- Melanotan II User Experience: A Qualitative Study of Online Discussion Forums. (2021) pubmed
- CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists. (2022) pubmed
- Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism. (2019) pubmed
- Discovery and development of novel melanogenic drugs. Melanotan-I and -II. (1998) pubmed
- Use of melanotan I and II in the general population. (2009) pubmed
- Melanotan II, a melanocortin agonist, partially rescues the impaired thermogenic capacity of pituitary adenylate cyclase-activating polypeptide deficient mice. (2021) pubmed
- Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for food. (2022) pubmed
- Melanotan II injection resulting in systemic toxicity and rhabdomyolysis. (2012) pubmed